Anlon Healthcare Ltd vs Occl Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 121.35 as of 20 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2023 to 0 on March 2022 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of OCCL Ltd changed from 18.5 on March 2025 to 0 on March 2022 . This represents a CAGR of -100.00% over 3 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of OCCL Ltd changed from ₹ 397.31 crore on March 2025 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 3 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of OCCL Ltd for the Dec '25 is ₹ 114.62 crore as compare to the Sep '25 revenue of ₹ 120.62 crore. This represent the decline of -4.97% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of OCCL Ltd for the Dec '25 is ₹ 17.06 crore as compare to the Sep '25 ebitda of ₹ 20.21 crore. This represent the decline of -15.59% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The net profit of OCCL Ltd changed from ₹ -0.04 crore to ₹ 6.53 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2023 to 0 % on March 2022 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of OCCL Ltd changed from 34.98 % on March 2025 to 0 % on March 2022 . This represents a CAGR of -100.00% over 3 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About OCCL Ltd

OCCL Limited was incorporated on April 25, 2022, at Mundra, Kachchh, Gujarat with a Certificate of Incorporation issued by the RoC. The Company belongs to the AG Ventures Group of companies.
The Company's first insoluble sulphur manufacturing facility, (transferred from demerged entity), was set up in 1994 in Dharuhera to manufacture insoluble sulphur, now its flagship product. The Company manufactures commercial grade and battery grade sulphuric acid and oleum at its Dharuhera Plant.
The Company's state-of-the-art manufacturing facilities are located in Dharuhera in Haryana and Mundra in Gujarat. The Company commenced production of Sulphuric Acid in 1978; commenced production capacity of 3,000 MT per annum Insoluble Sulphur in 1994; established a second line of business at Dharuhera in 2005; commenced construction of plant at Mundra in 2009; commissioned the first line of 5500 MTPA at Mundra Plant in 2011; commissioned the second line of insoluble sulphur at Mundra with production capacity of 5500 MTPA in 2012; expanded the additional 11,000 TPA of insoluble sulphur capacity at Mundra in 2016; commissioned the third line of insoluble sulphur with installed capacity of 5500 MTPA at Mundra Plant in 2017; commissioned the fourth line of insoluble sulphur with 5500 MTPA at Mundra in 2018; commissioned the expansion of 5500 MTPA insoluble sulphur at Dharuhera Plant in 2021; commissioned an additional 42000 MTPA capacity of sulphuric acid at Dharuhera Plant in 2022.

FAQs for the comparison of Anlon Healthcare Ltd and OCCL Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or OCCL Ltd?

Market cap of Anlon Healthcare Ltd is 644 Cr while Market cap of OCCL Ltd is 438 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and OCCL Ltd?

The stock performance of Anlon Healthcare Ltd and OCCL Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and OCCL Ltd?

As of March 22, 2026, the Anlon Healthcare Ltd stock price is INR ₹121.35. On the other hand, OCCL Ltd stock price is INR ₹87.85.

How do dividend payouts of Anlon Healthcare Ltd and OCCL Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and OCCL Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.